Literature DB >> 7815489

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.

C Liu1, M C Eichelberger, R W Compans, G M Air.   

Abstract

We have used a neuraminidase-deficient influenza virus, NWS-Mvi, which was selected by supplying bacterial neuraminidase in the medium (C. Liu and G. M. Air, Virology 194:403-407, 1993), to define the role of neuraminidase in influenza virus replication. Electron microscopy showed that virions of the NWS-Mvi mutant assembled normally and formed large aggregates associated with cell surfaces. The NWS-Mvi virus grown in the absence of neuraminidase was able to carry out a second round of replication in MDCK cells without added neuraminidase, indicating that the virus particles contained in these aggregates were infectious. Aggregates of virus were also found in cytoplasmic vacuoles. When virus-infected cells were incubated in the presence of ferritin, such aggregates were found to be labeled with ferritin, indicating that they are derived from uptake at the cell surface. When the neuraminidase-deficient virus was administered intranasally to C57BL/6 mice, low titers of virus were recovered from the lungs and major histocompatibility complex class I-restricted cytotoxic T cells were generated: evidence that cells were infected in vivo. In C57BL/6 nu/nu mice, the low level of virus persisted for at least 28 days but never increased. These results suggest that neuraminidase is not required for influenza virus entry, replication, or assembly in cell culture or in mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815489      PMCID: PMC188682     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Roles of alpha beta and gamma delta T cell subsets in viral immunity.

Authors:  P C Doherty; W Allan; M Eichelberger; S R Carding
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  The neuraminidase of influenza virus.

Authors:  G M Air; W G Laver
Journal:  Proteins       Date:  1989

3.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

4.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

6.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.

Authors:  W Allan; Z Tabi; A Cleary; P C Doherty
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

7.  Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.

Authors:  S Shibata; F Yamamoto-Goshima; K Maeno; T Hanaichi; Y Fujita; K Nakajima; M Imai; T Komatsu; S Sugiura
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes.

Authors:  C Liu; G M Air
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

9.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

10.  Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus.

Authors:  S Li; J Schulman; S Itamura; P Palese
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  130 in total

1.  Analysis of inhibitor binding in influenza virus neuraminidase.

Authors:  B J Smith; P M Colman; M Von Itzstein; B Danylec; J N Varghese
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Influenza virus matrix protein is the major driving force in virus budding.

Authors:  P Gómez-Puertas; C Albo; E Pérez-Pastrana; A Vivo; A Portela
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells.

Authors:  Sangkon Oh; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens.

Authors:  Diane J Hulse; Robert G Webster; Rupert J Russell; Daniel R Perez
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.

Authors:  Kathryn A Hooper; Jesse D Bloom
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

7.  Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins.

Authors:  Song Wang; Hua Li; Yuhai Chen; Haitao Wei; George F Gao; Hongqiang Liu; Shile Huang; Ji-Long Chen
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

8.  Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein.

Authors:  Shinji Watanabe; Masaki Imai; Yoshiro Ohara; Takato Odagiri
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Authors:  Andreas Handel; Victoria Akin; Sergei S Pilyugin; Veronika Zarnitsyna; Rustom Antia
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

10.  Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses.

Authors:  Yulia Shtyrya; Larisa Mochalova; Galina Voznova; Irina Rudneva; Aleksandr Shilov; Nikolai Kaverin; Nicolai Bovin
Journal:  Glycoconj J       Date:  2008-07-26       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.